Amplify Weight Loss Drug & Treatment ETF (THNR) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Amplify Weight Loss Drug & Treatment ETF (THNR) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $3.2M, listed on AMEX, carrying a beta of 0.41 to the broader market. THNR provides access to global companies expected to economically benefit from weight loss drug development. public since 2024-05-21.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for THNR as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →